FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Arizona Daily Star1d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
NOCISCAN touted as lumbar pain diagnostic advance
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company with a market capitalization of ...
BioPharma Dive1d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
St George News1d
Southern Utah doctors provide long-lasting relief for low back pain
Chronic low back pain can disrupt your daily life, keeping you from enjoying family moments, outdoor adventures or even ...
FDA approves new type of non-opioid pain medication in two decades
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
clinicalpainadvisor.com1d
Chronic Pain Among Women in Rheumatology — Prioritizing Unmet Needs
Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.
Labroots1d
Scientists Find Biomarkers of Pain Sensitivity
Researchers have identified two biomarkers that can reveal how sensitive an individual is to pain, and may offer new approaches for treating pain... | Clinical And Molecular Dx ...